New Roots For New Molecules: Ingredion-Sanstar To Commission Specialty Pharma Ingredients Plant

The Ingredion-Sanstar partnership brings together two complementary players to address growing demand for high-purity pharmaceutical excipients and specialty ingredients in India and export markets. The greenfield facility signals a strategic bet on the expanding pharmaceuticals and nutraceuticals supply chain.

What The Greenfield Project Aims To Build

The joint initiative to commission a greenfield plant focuses on specialty pharmaceutical and other ingredients, which are in high demand across drug formulation, nutraceutical and food-grade applications. A dedicated facility allows both companies to scale output with precision engineering, regulatory-grade manufacturing standards and consistent quality protocols.

Why This Partnership Makes Strategic Sense

Ingredion brings decades of global expertise in specialty ingredients including modified starches, sweeteners and texture systems used across pharmaceutical and food applications. Sanstar, a fast-growing Indian starch derivatives company, adds local manufacturing muscle, raw material access and established customer relationships in domestic and export markets.

Market Opportunity In Specialty Pharma Ingredients

India's pharmaceutical sector is the world's third largest by volume, and demand for high-quality excipients and specialty ingredients is rising steadily as formulation complexity increases. A greenfield plant optimised for pharmaceutical-grade production positions both companies to capture a share of this multi-billion rupee opportunity.

Key Highlights

• Ingredion and Sanstar to jointly commission a greenfield specialty ingredients plant
• Project targets pharmaceutical and other high-value specialty ingredient categories
• Partnership combines Ingredion's global expertise with Sanstar's domestic manufacturing strength
• Facility aims to meet rising pharmaceutical-grade excipient demand in India and exports

Sources: Sanstar corporate filings, Ingredion pharma investments update, Nutraceuticals World, Custom Market Insights, Mordor Intelligence